Imperial College London

ProfessorMarcGunter

Faculty of MedicineSchool of Public Health

Chair in Cancer Epidemiology
 
 
 
//

Contact

 

+44 (0)20 7594 2623m.gunter

 
 
//

Location

 

VC2Medical SchoolSt Mary's Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Obon-Santacana:2015:10.1158/1055-9965.EPI-15-0822,
author = {Obon-Santacana, M and Lujan-Barroso, L and Travis, RC and Freisling, H and Ferrari, P and Severi, G and Baglietto, L and Boutron-Ruault, M-C and Fortner, RT and Ose, J and Boeing, H and Menendez, V and Sanchez-Cantalejo, E and Chamosa, S and Huerta, Castano JM and Ardanaz, E and Khaw, K-T and Wareham, N and Merritt, MA and Gunter, MJ and Trichopoulou, A and Papatesta, E-M and Klinaki, E and Saieva, C and Tagliabue, G and Tumino, R and Sacerdote, C and Mattiello, A and Bueno-de-Mesquita, HB and Peeters, PH and Onland-Moret, NC and Idahl, A and Lundin, E and Weiderpass, E and Vesper, HW and Riboli, E and Duell, EJ},
doi = {10.1158/1055-9965.EPI-15-0822},
journal = {Cancer Epidemiology Biomarkers & Prevention},
pages = {127--134},
title = {Acrylamide and Glycidamide Hemoglobin Adducts and Epithelial Ovarian Cancer: A Nested Case-Control Study in Nonsmoking Postmenopausal Women from the EPIC Cohort},
url = {http://dx.doi.org/10.1158/1055-9965.EPI-15-0822},
volume = {25},
year = {2015}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - Background: Acrylamide was classified as “probably carcinogenic to humans (group 2A)” by the International Agency for Research on Cancer. Epithelial ovarian cancer (EOC) is the fourth cause of cancer mortality in women. Five epidemiological studies have evaluated the association between EOC risk and dietary acrylamide intake assessed using food frequency questionnaires, and one nested case–control study evaluated hemoglobin adducts of acrylamide (HbAA) and its metabolite glycidamide (HbGA) and EOC risk; the results of these studies were inconsistent.Methods: A nested case–control study in nonsmoking postmenopausal women (334 cases, 417 controls) was conducted within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Unconditional logistic regression models were used to estimate ORs and 95% confidence intervals (CI) for the association between HbAA, HbGA, HbAA+HbGA, and HbGA/HbAA and EOC and invasive serous EOC risk.Results: No overall associations were observed between biomarkers of acrylamide exposure analyzed in quintiles and EOC risk; however, positive associations were observed between some middle quintiles of HbGA and HbAA+HbGA. Elevated but nonstatistically significant ORs for serous EOC were observed for HbGA and HbAA+HbGA (ORQ5vsQ1, 1.91; 95% CI, 0.96–3.81 and ORQ5vsQ1, 1.90; 95% CI, 0.94–3.83, respectively); however, no linear dose–response trends were observed.Conclusion: This EPIC nested case–control study failed to observe a clear association between biomarkers of acrylamide exposure and the risk of EOC or invasive serous EOC.Impact: It is unlikely that dietary acrylamide exposure increases ovarian cancer risk; however, additional studies with larger sample size should be performed to exclude any possible association with EOC risk.
AU - Obon-Santacana,M
AU - Lujan-Barroso,L
AU - Travis,RC
AU - Freisling,H
AU - Ferrari,P
AU - Severi,G
AU - Baglietto,L
AU - Boutron-Ruault,M-C
AU - Fortner,RT
AU - Ose,J
AU - Boeing,H
AU - Menendez,V
AU - Sanchez-Cantalejo,E
AU - Chamosa,S
AU - Huerta,Castano JM
AU - Ardanaz,E
AU - Khaw,K-T
AU - Wareham,N
AU - Merritt,MA
AU - Gunter,MJ
AU - Trichopoulou,A
AU - Papatesta,E-M
AU - Klinaki,E
AU - Saieva,C
AU - Tagliabue,G
AU - Tumino,R
AU - Sacerdote,C
AU - Mattiello,A
AU - Bueno-de-Mesquita,HB
AU - Peeters,PH
AU - Onland-Moret,NC
AU - Idahl,A
AU - Lundin,E
AU - Weiderpass,E
AU - Vesper,HW
AU - Riboli,E
AU - Duell,EJ
DO - 10.1158/1055-9965.EPI-15-0822
EP - 134
PY - 2015///
SN - 1538-7755
SP - 127
TI - Acrylamide and Glycidamide Hemoglobin Adducts and Epithelial Ovarian Cancer: A Nested Case-Control Study in Nonsmoking Postmenopausal Women from the EPIC Cohort
T2 - Cancer Epidemiology Biomarkers & Prevention
UR - http://dx.doi.org/10.1158/1055-9965.EPI-15-0822
UR - http://hdl.handle.net/10044/1/42531
VL - 25
ER -